Labo Dr Clavel retweeted
#Toutlemondeenrouge à Plaza Laval (Québec) c'est parti. Mesdames venez parler de santé cardiovasculaire et faire écouter votre coeur. #cwhha
Labo Dr Clavel retweeted
The buzz is on at #CSEcho2025 - We are getting underway with the opening Symposium on Prosthetic valves!! @WilliamZoghbi @AllanLKleinMD1 @IgalSebag @amerjohri @CSEchoCa
Labo Dr Clavel retweeted
Congrats to @drsabede for being recognized as the inaugural recipient of the prestigious Tony Sanfilippo Mentor of the year Award at #CSecho2025. Very well deserved!
Labo Dr Clavel retweeted
Blood biomarkers in left-sided valvular heart disease academic.oup.com/eurheartj/a…
Labo Dr Clavel retweeted
🚨Our last publication. Emerging biomarker, Human Epididymis Protein 4 in Transcatheter Aortic Valve Implantation: Diagnostic and Prognostic Value | JACC: Advances jacc.org/doi/10.1016/j.jacad…
Great job!
Labo Dr Clavel retweeted
Marie-Annick Clavel (@ClavelLabo), professeure à l’Université Laval, présente la vision du plan stratégique pour les 10 prochaines années, en mettant l’accent sur la formation et l’éducation. #CWHHS2025
@cwhhs
@CWHHC
@HeartandStroke
Labo Dr Clavel retweeted
Angiotensin receptor blockers reduced aortic valve calcification (#yesCT) progression in patients with moderate aortic stenosis and hypertension @ClavelLabo @PPibarot @universitelaval @IUCPQ #AHAJournals ahajrnls.org/4jovR9W
Labo Dr Clavel retweeted
#CWHHS2025: Reflecting on the past, Empowering the present, and Shaping the future.
Hosted by @CWHHC & @HeartandStroke this conference focuses exclusively on the unique aspects of heart, brain and vascular health in women.
Register today: WomensHeartSummit.ca
Labo Dr Clavel retweeted
Aortic valve calcification is accurate in predicting aortic stenosis severity and outcomes in low flow AS. In low EF patients, lower AVC is associated with higer mortality @ClavelLabo @PPibarot @IUCPQ @universitelaval #AHAJournals @JiwonKimMD @kaznegishi
ahajrnls.org/4ae21Bf
Labo Dr Clavel retweeted
Congratulations to Dr. Marie-Annick Clavel for winning the 2024 Mid-Career Lecturer Award in Cardiovascular Sciences!
Dr. Clavel presented her research at the Canadian Cardiovascular Congress #CCCongress.
Her outstanding work specifying sex differences in the pathophysiology and response to the treatment of patients with aortic valve disease is important in advancing our ability to improve outcomes for women.
Thank you to the Canadian Cardiovascular Society for their continued partnership with the Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research @CIHR_IRSC.
@SCC_CCS
Labo Dr Clavel retweeted
2024 CCS/CIHR-ICRH Mid-Career Lecturer Award in CV Sciences Award handed to Dr. Marie-Annick Clavel, congratulations to an inspiring mentor who has broken many barriers for women's heart health and for women in science, and who's certainly on the path to breaking many more.👏🏆🫀
Labo Dr Clavel retweeted
📖 Read about the potential impact of ARBs in modifying aortic valve remodeling in patients with moderate-severe aortic stenosis. A negative association between #ARB intake and valvular fibrosis was observed among women 👉 onlinecjc.ca/article/S0828-2… #AorticStenosis #CJC #OpenAccess
Labo Dr Clavel retweeted
🫀 Calcific aortic stenosis is orchestrated by several pathways in which sex-specificities are involved. Considering these differences is essential to develop #AS medication. Read more 👉 cjcopen.ca/article/S2589-790… #CJCO #OpenAccess
Labo Dr Clavel retweeted
Adjudication of Low-Flow, Low-Gradient Aortic Stenosis Severity: Dobutamine Stress Echocardiography and MSCT Are Complementary, Not Competitive | JACC: Cardiovascular Imaging jacc.org/doi/10.1016/j.jcmg.… @SFCvalves @ElenaGalli10
Labo Dr Clavel retweeted
Moderate aortic stenosis could be defined by MDCT valve calcium scoring: 400-1300AU in women, 1000-2000AU in men. #AHAJournals @PPibarot @ClavelLabo @IUCPQ @universitelaval ahajrnls.org/3SDy9Xt
Labo Dr Clavel retweeted
In cardiac amyloidosis patients, 15% had aortic stenosis (AS). ATTRwt patients (26% AS) should be screened for AS. #AHAJournals @ClavelLabo @IUCPQ @universitelaval ahajrnls.org/3xJpWtK
Labo Dr Clavel retweeted
‼️🔖Cardiac damage staging predicts Outcomes post AVR across the AS symptom/severity spectrum
Glad to share our work published @JACCJournals led by @PhilGenereuxMD @MartyBLeon @docHJ @tavrkapadia @LindaGillamMD @PPibarot @djc795 @ClavelLabo @IbrahimSultanMD @M_Pompeu_Sa_MD
Labo Dr Clavel retweeted
Aortic valve calcification divided by the area of the aortic annulus measured by #yesCT allows a better prediction of AS severity and outcome @ClavelLabo #AHAJournals @JiwonKimMD @kaznegishi
ahajrnls.org/4bva1hg
Labo Dr Clavel retweeted
COME JOIN US to hear about the research being carried out on women’s heart health in Canada !!! @UAlbertaNursing @WCHRIUofA @SCC_CCS_CEO @SCC_CCS @WHCCanada @abwomenshealth
📢 Free Live Webinar tomorrow: Jan 9 @ 2-3 pm (EST)
➡️ Register today!!
ATLAS Chapter 8: Knowledge Gaps and Status of Existing #Research Programs in Canada
Read Ch 8: cjcopen.ca/article/S2589-790…
Learn more: cwhha.ca/cwhha-atlas
#HerHeartMatters @CJCJournals #CardioTwitter
Labo Dr Clavel retweeted
Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease @ClavelLabo
bit.ly/3rDqb61


































